Flavio Mantelli
Tracked across 4 events · 44 articles · First seen May 19, 2026 · Last active Jul 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Flavio Mantelli, Chief Medical Officer, highlighted the FDA feedback as an important milestone and de-risking of the development program.
Jul 08, 2026 · 9 articles
Business
Impact: Chief Medical Officer purchased 20,000 shares at $1.40.
Jul 21, 2026 · 22 articles
Business
Impact: Flavio Mantelli>>>, Chief Medical Officer of OKYO Pharma>>>, commented on the strengthening of the Scientific Advisory Board with Marta Sacchetti>>>'s appointment.
May 19, 2026 · 7 articles
Business
Impact: Chief Medical Officer of OKYO Pharma, presenting at the symposium.
Jul 07, 2026 · 6 articles
OKYO Pharma
cmo
↔
Flavio Mantelli
Flavio Mantelli is the Chief Medical Officer of OKYO Pharma, where he oversees t
ERGEN INTELLIGENCE
Track Flavio Mantelli live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard